Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-019641)

Filing Details

Accession Number:: 0001127602-12-019641
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-06-08 12:44:02
Reporting Period:: 2012-06-06

Filing Date:: 2012-06-08
Accepted Time:: 2012-06-08 12:44:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
940435	J William Motto	3471 River Hills Drive Cincinnati OH 45244	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-06-06	3,000	$19.50	79,458	No	4	S	Indirect	As Trustee For Charitable Remainder Unitrust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	As Trustee For Charitable Remainder Unitrust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	40,000	Direct
Common Stock	289,346	Indirect	By LLC
Common Stock	332,914	Indirect	By Trust

Footnotes

Prices range from $19.50 per share to $19.53 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
These shares are held by a limited liability company, of which the reporting person is Manager. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.